Search

Author/Creator von Mehren, M

1. 1603OInitial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens. (23rd October 2018)

Authors:
George, S; Heinrich, M; Chi, P; Razak, A; von Mehren, M; Gordon, M; Ganjoo, K N; Somaiah, N; Trent, J C; Rodon Ahnert, J; Wolf, J; Ruiz-Soto, R; Rosen, O; Janku, F
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1623PCorrelation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinib. (23rd October 2018)

Authors:
George, S; Bauer, S; Jones, R L; Serrano, C; von Mehren, M; Kang, Y-K; Schöffski, P; Cassier, P; Eskens, F A; Mir, O; Tap, W D; Chawla, S P; Rutkowski, P; Shi, H; Schmidt-Kittler, O; Mar, B; Heinrich, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. (2nd August 2018)

Authors:
Jones, R L; Demetri, G D; Schuetze, S M; Milhem, M; Elias, A; Van Tine, B A; Hamm, J; McCarthy, S; Wang, G; Parekh, T; Knoblauch, R; Hensley, M L; Maki, R G; Patel, S; von Mehren, M
Journal:
Annals of oncology
Issue:
Volume 29:Number 9(2018)
Page Start:
1995
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search